Research
What an asynchronous visit can and cannot assess
Store-and-forward care carries exactly what you sent and nothing else. That is its efficiency and its limit, and the two are the same property seen from different sides.
What the two models are
Federal telehealth guidance splits remote care into two shapes, and the split is about timing rather than technology.
Synchronous telehealth happens in real time, with clinician and patient communicating directly by video or audio. Asynchronous telehealth, also called store-and-forward, lets the two sides share information at different times.
In the asynchronous model the clinician reviews information the patient sent, and decides from it. The guidance names patient intake and follow-up care as its common uses, which is precisely where a peptide or weight-loss request usually sits.
Both are established, both are used across medicine, and neither is a workaround. They simply move different amounts of information.
What actually reaches the reviewer
The federal examples of asynchronous telehealth are concrete, and reading them as a list of channels is clarifying.
Secure text messages let a patient send questions and updates, which a clinician reviews and answers within some period. Captured images can be sent for a clinician to review later. Medical reports, lab results, digital imaging and health histories can be uploaded ahead of a decision.
Every item on that list has the same property. It is something the patient, or a lab, chose to send.
A reviewer working asynchronously is working from a submitted record. That record can be rich, especially when labs and images are part of it. It is still a record rather than a person in front of them.
The four things the channel cannot carry
Some information does not survive the trip, and it is worth naming plainly rather than treating as a vague reservation.
There is no follow-up question in the moment. In a live conversation an unexpected answer produces the next question. A form produces the next field, which was written before anyone knew your answer.
There is no observation you did not think to report. A clinician on video notices things a patient never thought worth mentioning. A form only receives what a patient decided to enter.
There is no physical examination and no measurement taken by anyone else. Height, weight, blood pressure and anything else are what you typed, unless a lab or a device supplied them.
And there is no shared timing. Guidance describes answers arriving within a certain period, which means the exchange is not a conversation but a sequence of one-way messages.
The tell in the federal guidance itself
The two federal pages are short, and the difference in how they describe each model is the most useful thing on them.
The benefits listed under asynchronous care are about the clinician's workflow. Flexibility, because no appointment has to be scheduled. Efficiency, because automated intake through online forms or remote devices standardizes the process.
Those are real advantages, and they are advantages of throughput. The page does not claim asynchronous review assesses more.
Under synchronous care, the first example given is a clinician evaluating a patient with an acute condition through live video. Assessment of a patient in front of you appears on that page and not the other.
That is not a ruling about safety, and neither page makes one. It is a description of what each channel is used for, written by the agency that publishes the guidance.
What narrows the gap
The gap between the two models is not fixed. Several things a provider can do close part of it, and each one is visible from outside.
Labs put measured values into the record instead of reported ones. Uploaded imaging does the same for anything visual. A remote device supplies readings a form cannot.
A live visit at the start, or at the point where a request becomes complicated, restores the follow-up question. So does a route back to a clinician afterward, rather than a support inbox.
A structured intake that asks about conditions, medications, allergies and pregnancy in detail collects more of what a clinician would have asked. It is still bounded by what you enter, but the boundary sits further out.
None of that turns store-and-forward review into a live examination. It does change how much of the picture arrives.
How to read a provider on this
The useful questions are about the channel rather than about the clinician's quality, which you cannot assess from a website anyway.
Which model is used for the first decision, and is that stated anywhere before checkout? If the answer is store-and-forward, what else feeds the record: labs, uploads, a device, nothing?
Is there a live visit available at all, and is it optional or built in? Is there a route back to a clinician after the first decision, and is it a clinician or a support queue?
A provider that answers those in public is describing its own information channel. A provider that says only that a licensed clinician reviews every request has described a step, not a channel.
Key takeaways
- Asynchronous, or store-and-forward, care means clinician and patient exchange information at different times.
- Federal guidance names patient intake and follow-up as its common uses, which is where most peptide requests sit.
- The channel carries only what was submitted: no follow-up question, no unreported observation, no examination.
- The benefits federal guidance lists for it are provider workflow ones, flexibility and efficiency.
- The same guidance puts evaluating a patient with an acute condition under real-time video instead.
- Labs, uploads, devices and a live visit each narrow the gap without closing it.
Frequently asked questions
What does "asynchronous" mean in telehealth?
It means clinician and patient exchange information at different times rather than in a live conversation. Federal guidance also calls it store-and-forward, and describes it as often used for patient intake or follow-up care, with the clinician reviewing information the patient sent, then diagnosing and treating from it. Common examples are secure messages answered within some period, images sent for later review, and uploaded lab results, medical reports or health histories.
Is an asynchronous visit a real medical visit?
It is a recognized model of care that appears in federal telehealth guidance alongside real-time video and audio, and a licensed clinician makes the decision in it. What differs is the information channel rather than the legitimacy. A store-and-forward exchange carries what was submitted, so there is no follow-up question in the moment, no observation the patient did not report, and no examination or measurement taken by a clinician.
Why do so many remote providers use it?
Federal guidance names the reasons directly, and both are workflow advantages. Flexibility, because no appointment has to be scheduled and the clinician reviews when it fits. Efficiency, because automated intake through online forms or remote devices streamlines and standardizes the process. Those benefits describe throughput. The same guidance puts evaluating a patient with an acute condition under the real-time model instead.
What makes a store-and-forward review more informative?
Anything that puts measured rather than reported information into the record. Labs supply values a form cannot. Uploaded imaging does the same for anything visual, and a remote monitoring device supplies readings over time. A live visit at the start, or a route back to a clinician afterward, restores the follow-up question that a form structurally cannot ask. None of that makes it a physical examination.
Should I prefer a provider that offers a video visit?
That is a decision about your own situation, and this site does not make it for you. What can be said is what each channel carries. A live visit adds real-time questioning and direct observation; a store-and-forward review adds speed and carries whatever was submitted. Both appear in federal guidance as legitimate. Knowing which one a provider uses, and what else feeds its record, is the part worth establishing before you pay.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- Asynchronous direct-to-consumer telehealth — Telehealth.HHS.gov, Health Resources and Services Administration, September 2024
- Synchronous direct-to-consumer telehealth — Telehealth.HHS.gov, Health Resources and Services Administration, September 2024
- Licensing across state lines — Telehealth.HHS.gov, Health Resources and Services Administration, April 2025